42 CFR 476.93: Opportunity to discuss proposed initial denial determination and changes as a result of a DRG validation.
Where this section sits in the code
- Title 42—Public Health
- CHAPTER IV—CENTERS FOR MEDICARE & MEDICAID SERVICES, DEPARTMENT OF HEALTH AND HUMAN SERVICES
- SUBCHAPTER F—QUALITY IMPROVEMENT ORGANIZATIONS
- PART 476—QUALITY IMPROVEMENT ORGANIZATION REVIEW
- Subpart C—Review Responsibilities of Quality Improvement Organizations (QIOs)
Before a QIO reaches an initial denial determination or makes a change as a result of a DRG validation, it must—
(a) Promptly notify the provider or supplier and the patient's attending physician (or other attending health care practitioner) of the proposed determination or DRG change; and
(b) Afford an opportunity for the provider or supplier and the physician (or other attending health care practitioner) to discuss the matter with the QIO physician advisor and to explain the nature of the patient's need for health care services, including all factors which preclude treatment of the patient as an outpatient or in an alternative level of inpatient care.
Collected 2026-08-27T02:26:11Z. Source file · JSON